Dr Kai Pinkernell | Chief Medical Officer & Senior Vice President of Medical Affairs
Medigene Ag

Dr Kai Pinkernell, Chief Medical Officer & Senior Vice President of Medical Affairs, Medigene Ag

Dr. Kai Pinkernell is Senior Vice President Medical Affairs, Chief Medical Officer, at Medigene AG and responsible for clinical and GMP process development. Medigene AG is a stock listed (Frankfurt: MDG1, Prime Standard) biotechnology company with its headquarters in Martinsried, Munich. Medigene concentrates on the development of personalized immunotherapies with a focus on hematooncology

Previously, Dr. Pinkernell was the Global Head of Clinical Business at Miltenyi Biotec GmbH, leading clinical marketing, sales and development, worldwide. Also, Dr. Pinkernell has been with Cytori Therapeutics Inc., San Diego, USA, from 2005 to 2009, as Senior Director of Regenerative Cell Technology and Clinical Applications Director. He received his medical degree from the Westfaelische-Wilhems University in Muenster, Germany, and pursued a residency/fellowship in internal medicine/cardiology at the German Heart Center and Klinikum Rechts der Isar, Technical University, in Munich, Germany. He further received a Master of Business Administration from the Marshall School of Business at the University of Southern California, Los Angeles, USA.


Day 2 Oct 11th Immune Profiling @ 09:10

Development of TCR based adoptive T cell therapies: opportunities and challenge

  • Discovery and Development of T-cells for immunotherapies
  • Identifying patient populations and expanding the responding population
  • TCR targeting of neoantigens
  • Addressing potential challenges in cell based immunotherapies

back to speakers